Skip to main content

Advertisement

Log in

Relationship between aortic valve sclerosis and left ventricular hypertrophy in chronic haemodialysis patients

  • Original Article
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Cardiac valve calcification is a frequent finding in chronic haemodialysis patients. Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular mortality in patients with end-stage renal disease. We evaluated the influence of aortic valve sclerosis (AVS) on the development of LVH in chronic haemodialysis patients.

Methods

A total of 82 consecutive patients (52 male, mean age 48 ± 12 years) undergoing chronic haemodialysis treatment for >1 year were subjected to echocardiography for the screening of AVS and the assessment of transaortic flow velocity and the left ventricular mass index (LVMI). The absence (group 1, n = 42) and presence of AVS (group 2, n = 40) was established. The average values of systolic, diastolic and pulse pressure were obtained. Plasma calcium, phosphorus, intact parathyroid hormone, C-reactive protein, haemoglobin and lipid levels were also measured.

Results

LVH was detected in 59 (72%) of the study patients. The LVMI was higher in the AVS group (171 ± 39 vs. 132 ± 41 g/m2, p < 0.001). Patients with AVS also had higher transaortic flow velocities (1.64 ± 0.36 vs. 1.21 ± 0.21 m/s, p < 0.01) and maximal pressure gradients (10.8 ± 7.1 vs. 5.9 ± 3.4 mmHg, p < 0.01). The LVMI showed a direct correlation with transaortic flow velocity in the AVS group (r = 0.60, p < 0.01). Stepwise linear regression analysis revealed transaortic flow velocity (p = 0.02), pulse pressure (p = 0.01) and haemoglobin levels (inverse relationship) (p = 0.02) to be independent predictors of the LVMI.

Conclusion

These data suggest that AVS is strongly and independently interrelated with LVH in chronic haemodialysis patients. The underlying mechanism might be the valve resistance to left ventricular outflow, as shown by increased transaortic flow velocities and maximal pressure gradients in AVS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Zoccali C, Benedetto FA, Mallamaci F et al (2001) Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12:2768–2774

    PubMed  CAS  Google Scholar 

  2. Paoletti E, Specchia C, Di Maio G et al (2004) The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 19:1829–1834

    Article  PubMed  Google Scholar 

  3. London GM (2003) Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16:85–94

    Article  PubMed  Google Scholar 

  4. Parfrey PS, Foley RN (1999) The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606–1615

    PubMed  CAS  Google Scholar 

  5. Ventura JE, Tavella N, Romero C et al (2002) Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 17:1795–1801

    Article  PubMed  CAS  Google Scholar 

  6. Maher ER, Pazianas M, Curtis JR (1987) Calcific aortic stenosis: a complication of chronic uraemia. Nephron 47:119–122

    Article  PubMed  CAS  Google Scholar 

  7. Ureña P, Malergue MC, Goldfarb B et al (1999) Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie 20:217–225

    PubMed  Google Scholar 

  8. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of LDL-cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    PubMed  CAS  Google Scholar 

  9. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618

    PubMed  CAS  Google Scholar 

  10. Dubois D, Dubois EF (1915) The measurement of the surface area of man. Arch Intern Med 16:868–881

    Google Scholar 

  11. Stewart BF, Siscovick D, Lind BK et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29:630–634

    Article  PubMed  CAS  Google Scholar 

  12. Otto CM, Lind BK, Kitzman DW et al (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147

    Article  PubMed  CAS  Google Scholar 

  13. Maher ER, Young G, Smyth-Walsh B et al (1987) Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2:875–877

    Article  PubMed  CAS  Google Scholar 

  14. Straumann E, Meyer B, Misteli M et al (1992) Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 67:236–239

    Article  PubMed  CAS  Google Scholar 

  15. Ribeiro S, Ramos A, Brandão A et al (1998) Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 13:2037–2040

    Article  PubMed  CAS  Google Scholar 

  16. Pohle K, Mäffert R, Ropers D et al (2001) Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104:1927–1932

    Article  PubMed  CAS  Google Scholar 

  17. Kajbaf S, Veinot JP, Ha A et al (2005) Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis 46:86–93

    Article  PubMed  Google Scholar 

  18. Movillia E, Feliciania A, Camerini C et al (2005) A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. Nephron Clin Pract 101:c161–c167

    Article  CAS  Google Scholar 

  19. Torun D, Sezer S, Baltali M et al (2005) Association of cardiac valve calcification and inflammation in patients on hemodialysis. Ren Fail 27:221–226

    Article  PubMed  CAS  Google Scholar 

  20. Klassen PS, Lowrie EG, Reddan DN et al (2002) Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc 287:1548–1555

    Article  Google Scholar 

  21. Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434–2439

    PubMed  CAS  Google Scholar 

  22. London GM, Marchais SJ, Safar ME et al (1990) Aortic and large artery compliance in end-stage renal failure. Kidney Int 37:137–142

    Article  PubMed  CAS  Google Scholar 

  23. Yıldız A, Memisoglu E, Oflaz H et al (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760–767

    Article  PubMed  Google Scholar 

  24. Amann K, Rychlik I, Miltenberger-Mitteny G et al (1998) Left ventricular hypertrophy in renal failure. Kidney Int 54(Suppl 68):S78–S85

    Article  Google Scholar 

  25. Meeus F, Kourilsky O, Guerin AP et al (2000) Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int 58(Suppl 76):S140–S147

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayse Emre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turkmen, F., Emre, A., Ozdemir, A. et al. Relationship between aortic valve sclerosis and left ventricular hypertrophy in chronic haemodialysis patients. Int Urol Nephrol 40, 497–502 (2008). https://doi.org/10.1007/s11255-007-9317-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-007-9317-4

Keywords

Navigation